Recent CLSD News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:06:09 PM
- Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process • GlobeNewswire Inc. • 11/24/2025 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 08:10:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2025 11:24:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2025 11:16:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2025 08:30:28 PM
- Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress • GlobeNewswire Inc. • 08/26/2025 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 08:05:49 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/04/2025 12:00:10 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/25/2025 08:11:36 PM
- Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery • IH Market News • 07/23/2025 12:08:34 PM
- Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada • GlobeNewswire Inc. • 07/23/2025 11:05:00 AM
- Clearside Biomedical shares dip after announcing exploration of strategic alternatives • IH Market News • 07/17/2025 12:38:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2025 11:15:26 AM
- Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline • GlobeNewswire Inc. • 07/17/2025 11:05:00 AM
- Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting • GlobeNewswire Inc. • 06/17/2025 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2025 08:05:12 PM
- Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum • GlobeNewswire Inc. • 05/21/2025 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:10:10 PM
- Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2025 08:05:00 PM
- Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting • GlobeNewswire Inc. • 05/09/2025 11:05:00 AM
- Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 • GlobeNewswire Inc. • 05/08/2025 11:05:00 AM
- Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 05/01/2025 11:05:00 AM
